Daily News » Cancer

Tobacco Research Reveals The Packet Racket

admin — Wed, 14 Oct 2009 08:37:49 +0000

The tobacco industry has side stepped laws banning advertising and promotion by skilfully marketing cigarettes to reel in smokers according to a new Cancer Research UK study* yesterday (Monday). Between 2003 and 2005 the Tobacco Advertising and Promotions Act (TAPA) outlawed all tobacco advertising.
By medicalnewstoday.com

Loss Of Tumor Supressor Gene Essential For Transformation Of Benign Nerve Tumors Into Deadly Type Of Sarcoma

admin — Wed, 14 Oct 2009 08:37:49 +0000

Researchers at UCLA’s Jonsson Comprehensive Cancer Center showed for the first time that the loss or decreased expression of the tumor suppressor gene PTEN plays a central role in the malignant transformation of benign nerve tumors called neurofibromas into a malignant and extremely deadly form of sarcoma.
By medicalnewstoday.com

Magnetic Nanotags Spot Cancer In Mice Earlier Than Methods Now In Clinical Use

admin — Wed, 14 Oct 2009 08:37:49 +0000

Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip. The sensor is up to 1,000 times more sensitive than technology now in clinical use, accurate regardless of which bodily fluid is being analyzed and can detect biomarker proteins over a concentration range three times broader than existing methods.
By sciencedaily.com

Cancer Passes From Mother To Unborn Child

admin — Wed, 14 Oct 2009 08:37:49 +0000

A team of scientists from Japan and the UK has published a paper describing a case of a mother with cancer passing the disease to her unborn child and how they proved it. The study was the work of first author Takeshi Isoda from the Department of Pediatrics and Developmental Biology at Tokyo Medical and Dental University, and colleagues, and appears in the 12 October online issue of the Proceedings of the National Academy of Sciences, PNAS.
By medicalnewstoday.com

Triggers Found In Cells’ Transition From Colitis To Cancer

admin — Wed, 14 Oct 2009 08:37:49 +0000

In findings that may help explain why patients with colitis have up to a 30-fold risk of developing colon cancer compared with people without the disease, researchers reveal that inflamed but noncancerous colon tissue taken from human patients transformed into tumors in mice.
By sciencedaily.com

Scientists Solve 100-year Cancer Puzzle

admin — Wed, 14 Oct 2009 08:37:49 +0000

A rare case of a mother and her infant developing the exact same cancer has allowed an international team of researchers to solve a puzzle that has perplexed scientists and clinicians for a century. Scientists at The Institute of Cancer Research (ICR) and colleagues in Japan, with funding from
By medicalnewstoday.com

OncoLink at PTCOG 2009

admin — Wed, 14 Oct 2009 08:37:49 +0000

OncoLink reporters provide up-to-date coverage of the Particle Therapy Cooperative Group (PTCOG) 48 Conference in Heidelberg, Germany, September 28 – October 3, 2009.
By oncolink.org

Bioluminescence Imaging Used For Eye Cancer Detection

admin — Wed, 14 Oct 2009 08:37:49 +0000

At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging, will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn’t necessarily involve eye surgery.
By sciencedaily.com

European Patent Office To Issue Patent To Phyton Biotech Covering Methods Of Making Taxanes – Compounds Useful In Cancer Treatment

admin — Wed, 14 Oct 2009 08:37:49 +0000

Phyton Biotech GmbH, a world leader in plant cell culture technology, reports that the European Patent Office has announced its intention to grant a European patent to Phyton covering methods of producing taxanes such as paclitaxel. Paclitaxel, the active ingredient in Bristol-Myers Squibb’s TAXOL®, is useful in the treatment of breast, ovarian, lung, and other forms of cancer.
By medicalnewstoday.com

Texas State Tests Potential New Cancer-Fighting Weapon

admin — Wed, 14 Oct 2009 08:37:48 +0000

Researchers at Texas State University-San Marcos have completed initial testing of a cancer chemotherapeutic and anti-retroviral compound with promising results. Dhiraj Vattem, professor in the Department of Family and Consumer Sciences, and Reed Richardson, professor in the Department of Agriculture, supervised the tests in cooperation with Orizon Research. Results were announced at a University press conference.
By medicalnewstoday.com